(Q61894570)

English

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase II Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-Host -Exhausting and Timely Dose-Reduced Mel-80-CFZ-TD-Pace Transplant(s) With Interspersed Mel-20-CFZ-TD-Pace With CFZ-RD and CFZ-D Maintenance (English)

0 references

medical condition

multiple myeloma

0 references

sponsor

University of Arkansas

0 references

country

United States of America

0 references

start time

August 2014